Showing results (61-70 of 144) with videos related to
Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral populationNicolas Wentzensen, Lauren Schwartz, Rosemary E Zuna, et al.Cancer|November 7, 2003
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkersMichele Follen, Frank L Meyskens, Ronald D Alvarez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2Joan L Walker, Marion R Piedmonte, Nick M Spirtos, et al.Gynecologic Oncology|June 21, 2018
A phase II evaluation of sunitinib in the treatment of persistent or recurrent clear cell ovarian carcinoma: An NRG Oncology/Gynecologic Oncology Group Study (GOG-254)John K Chan, William Brady, Bradley J Monk, et al.Gynecologic Oncology|November 13, 2016
Effectiveness of cyanoacrylate microbial sealant in the reduction of surgical site infection in gynecologic oncology procedures: A phase III single institution prospective randomized trialEric D Thomas, Elizabeth K Nugent, Matthew C MacAllister, et al.Cancer Cytopathology|October 24, 2018
Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosisRachel D Conrad, Angela H Liu, Nicolas Wentzensen, et al.Gynecologic Oncology|May 23, 2008
Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?Kathleen N Moore, Monica S Reid, Daniel N Fong, et al.Gynecologic Oncology|September 5, 2018
Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group studyWilliam P Tew, Michael W Sill, Joan L Walker, et al.Cancer Causes & Control : CCC|October 18, 2012
A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group studyRandy L Carter, Le Kang, Kathleen M Darcy, et al.Gynecologic Oncology|September 5, 2012
A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group studyNatalie Gould, Michael W Sill, Robert S Mannel, et al.Pageof 15